Assessment of Erythropoiesis-Stimulating Agents for Anemia Treatment among Chronic Kidney Disease Patients: A Descriptive, Retrospective Study

Background: Renal anemia is a cause of significant morbidity, and to lesser extent mortality in patients with chronic kidney disease (CKD), the leading causes of anemia in CKD primarily are the lack of erythropoietin (EPO) and iron. Thus, effective management is possible using oral and intravenous (...

Full description

Bibliographic Details
Main Authors: Zeinab Mohamed Elamin, Safaa Badi, Bashir Alsiddig Yousef
Format: Article
Language:English
Published: Zibeline International 2021-01-01
Series:Matrix Science Medica
Subjects:
Online Access:http://www.matrixscimed.org/article.asp?issn=2521-0807;year=2021;volume=5;issue=1;spage=21;epage=24;aulast=Elamin

Similar Items